U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 1 Bronchospasm, CTCAE

MedGen UID:
1641331
•Concept ID:
C4685061
•
Finding

Definition

Mild symptoms; intervention not indicated [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 1 Bronchospasm, CTCAE

Recent clinical studies

Etiology

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ
Oncologist 2012;17(3):321. Epub 2012 Feb 23 doi: 10.1634/theoncologist.2010-0265. PMID: 22363068Free PMC Article

Therapy

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ
Oncologist 2012;17(3):321. Epub 2012 Feb 23 doi: 10.1634/theoncologist.2010-0265. PMID: 22363068Free PMC Article

Clinical prediction guides

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ
Oncologist 2012;17(3):321. Epub 2012 Feb 23 doi: 10.1634/theoncologist.2010-0265. PMID: 22363068Free PMC Article

Supplemental Content

Table of contents

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...